10/6/2026
DemeRx appoints ibogaine expert Juan Sanchez-Ramos
Sanchez-Ramos joins as DemeRx advances its alcohol use disorder program.
Topic archive
alcohol use disorder
2 stories
8/7/2026
Psyence Biomedical unveils strategic plans in new investor presentation
Psyence Biomedical outlines its focus on psychedelic therapeutics for mental health in a recent investor update.